What’s Next? Five Things To Look Out For In November
Another Avastin Biosimilar Could Be Approved In US
In November, ANI Pharmaceuticals is hoping to complete a major acquisition, Viatris may shed further light on the state of the US generics industry and Generics Bulletin will host its eighth annual Global Generics & Biosimilars Awards, this year once again in person.
